Loading…

Loading grant details…

Active HORIZON European Commission

Mechanical Characterisation of Nucleic Acids using Single Molecule Methods


Funder European Commission
Recipient Organization Chalmers Tekniska Hogskola Ab
Country Sweden
Start Date Oct 01, 2024
End Date Sep 30, 2028
Duration 1,460 days
Number of Grantees 12
Roles Participant; Associated Partner; Coordinator
Data Source European Commission
Grant ID 101168851
Grant Description

Nucleic acid (NAs)-based therapies have started to yield major advances in the treatment of human disease.

New approaches for understanding NA structure and function are required to extend the boundaries of todays gene editing technologies, cancer therapies, and mRNA vaccines.

Single-molecule techniques have revolutionised our understanding of NAs and their interactions with therapeutic oligonucleotides, small molecules, and proteins.

However, for Europe to remain competitive in this area, new expertise is urgently required in single-molecule NA analysis, which intersects the fields of physical chemistry, biophysics, NA synthesis, and computation.

MeChaNiSM will train the next generation of European scientific leaders in the development and use of single-molecule biophysics techniques where they will investigate critical interrelated question regarding the structure, dynamics, function, and interactions of NAs.

To do this, our Doctoral Candidates (DCs) will:- Unravel high-resolution NA structures and intramolecular forces with modified bases- Understand the conformation and dynamics of NAs at the single-molecule level- Develop next-generation therapeutics for treating genetic diseasesMeChaNiSM connects world-leading researchers working in the fields of single-molecule biophysics, NA chemistry, and computational modeling with outstanding industrial partners working in complementary fields.

In addition to conducting world-class research, our DCs will understand industrial needs, have know-how in running multidisciplinary research, and will be immersed in a broad collaborative network connecting academia and industry.

Our DCs will provide vital future breakthrough applications in NAs and single-molecule analysis to pharmaceutical and biotechnological industries where the design of new drugs - including NA-based therapeutics and vaccine technologies - will provide major improvements to human health.

All Grantees

Stichting Vu; Dublin City University; Lumicks Bv; Nanotemper Technologies Gmbh; Astrazeneca Ab; Universitat Zu Koln; Universitat de Barcelona; Universitaet Augsburg; National Institute for Bioprocessing Research and Training Limited; Katholieke Universiteit Leuven; Universiteit Van Amsterdam; Chalmers Tekniska Hogskola Ab

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant